基于网络药理学探讨麻黄定喘汤治疗哮喘的作用机制
Network Pharmacology Approach to Explore Mechanisms of Mahuang Dingchuan Decoction for Treatment of Asthma
DOI: 10.12677/TCM.2021.106104, PDF,    国家自然科学基金支持
作者: 张 骞*, 张欣月, 李江娅, 梁丽菊, 林浩畅, 翁稚颖#:昆明医科大学药学院暨云南省天然药物药理重点实验室,云南 昆明
关键词: 网络药理学麻黄定喘汤哮喘机制Network Pharmacology Mahuang Dingchuan Decoction Asthma Mechanisms
摘要: 目的:基于网络药理学方法分析麻黄定喘汤治疗哮喘的作用机制。方法:通过中药系统药理学数据库与分析平台(TCMSP)获取麻黄定喘汤中各药的主要化学成分与其靶点,依据ADME对活性组分进行筛选;通过Genecards,OMIM,DRUGBANK数据库获取哮喘主要靶点,两者取交集后通过String平台对交集靶点进行蛋白质相互作用分析,构建PPI网络并采用Cytoscape3.7.2软件对PPI网络中蛋白质功能模块进行挖掘。通过Metascape平台对交集靶点进行基因本体(GO)富集分析和京都基因与基因组百科全书(KEGG)通路富集分析。结果:从麻黄定喘汤中共得到化学成分188个,共涉及靶点247个,与哮喘相关的基因1051个,二者取交集后获得120个麻黄定喘汤治疗哮喘的靶标,包括信号转导和转录激活因子3 (STAT3)、毒蕈碱型乙酰胆碱受体M3 (CHRM3),α2A肾上腺素能受体(ADRA2A),μ阿片受体(OPRM1),趋化因子10 (CXCL10),趋化因子8 (CXCL8),分裂原活化蛋白激酶1 (MAPK1),肿瘤坏死因子(TNF)等核心靶点,GO富集分析与KEGG通路富集分析显示麻黄定喘汤可以影响细胞对毒性物质的反应,调控MAPK级联反应,调节糖尿病并发症中的AGE-RAGE信号通路,TNF信号通路,NF-κB信号通路等通路。结论:该研究预测了麻黄定喘汤治疗哮喘的潜在作用机制,初步揭示了麻黄定喘汤多成分、多靶点、多通路的作用特点。
Abstract: Objective: To explore the mechanisms of Mahuang Dingchuan Decoction in the treatment of asthma based on network pharmacology. Methods: Active ingredients and targets of Mahuang Dingchuan Decoction were collected from Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), screening of active ingredients based on ADME; tar-gets of asthma were retrieved from Genecards, OMIM, DRUGBANK database, after the intersec-tion of the two, the protein interaction analysis was performed on the intersection through String datebase, a protein interaction network was constructed and Cytoscape3.7.2 wad used to mine protein functional modules in the network. Gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were per-formed on the Metascape platform. Result: A total of 188 chemical components were obtained from Mahuang Dingchuan Decoction, involving 247 targets, and 1051 targets related to asthma, after the intersection,120 targets of Mahuang Dingchuan Decoction were determined to treat asthma, including Signal transducer and activator of transcription 3 (STAT3), Muscarinic ace-tylcholine receptor M3 (CHRM3), Alpha-2A adrenergic receptor (ADRA2A), Mu-type opioid re-ceptor (OPRM1), C-X-C motif chemokine 10 (CXCL10), Interleukin-8 (CXCL8), Mitogen-activated protein kinase 1 (MAPK1), Tumor necrosis factor (TNF) and other core targets. GO analysis and KEGG analysis prove that Mahuang Dingchuan Decoction can affect cellular response to toxic substance, regulation of MAPK cascade and regulate AGE-RAGE signaling pathway in diabetic complications, TNF signaling pathway, NF-kappa B signaling pathway and other pathway. Con-clusion: The study predicted the potential mechanisms of Mahuang Dingchuan Decoction in the treatment of asthma, and initially revealed the multi-component, multi-target, multi-pathway characteristics of Mahuang Dingchuan Decoction.
文章引用:张骞, 张欣月, 李江娅, 梁丽菊, 林浩畅, 翁稚颖. 基于网络药理学探讨麻黄定喘汤治疗哮喘的作用机制[J]. 中医学, 2021, 10(6): 748-761. https://doi.org/10.12677/TCM.2021.106104

参考文献

[1] 李鑫慧. 支气管哮喘的发病机制及临床药物治疗的进展[J]. 临床医药文献电子杂志, 2020, 7(96): 191-192.
[2] 吕巧玉, 麻文菁, 陶孟瑶, 徐文, 何燕. 小青龙汤治疗支气管哮喘研究进展[J]. 中国处方药, 2021, 19(2): 26-28.
[3] 赵欢欢, 王明航, 屠新敏, 杨江, 林晓红. 支气管哮喘炎症表型与中医证候的相关性[J]. 中国老年学杂志, 2021, 41(1): 215-218.
[4] 陈海彬, 周红光, 李文婷, 程海波, 吴勉华. 网络药理学——中药复方作用机制研究新视角[J]. 中华中医药杂志, 2019, 34(7): 2873-2876.
[5] 赵炳聪, 李亚鸿, 解红霞. 网络药理学在中药复方作用机制研究中的应用[J]. 中国中医药信息杂志, 2020, 27(3): 133-136.
[6] Li, S. and Zhang, B. (2013) Traditional Chinese Medicine Network Pharmacology: Theory, Methodology and Application. Chinese Journal of Natural Medicines, 11, 110-120. [Google Scholar] [CrossRef
[7] Ru, J., Li, P., Wang, J., et al. (2014) TCMSP: A Database of Systems Pharmacology for Drug Discovery from Herbal Medicines. Journal of Cheminformatics, 6, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
[8] 马璐, 田国祥, 耿辉, 王亚军, 张勇, 马茂, 吕军. 中药系统药理数据库TCMSP及其分析应用简介[J]. 中国循证心血管医学杂志, 2020, 12(12): 1413-1416.
[9] Szklarczyk, D., Gable, A.L., Lyon, D., et al. (2019) STRING v11: Protein-Protein Association Networks with Increased Coverage, Supporting Functional Discovery in Genome-Wide Experimental Datasets. Nucleic Acids Research, 47, D607-D613. [Google Scholar] [CrossRef] [PubMed]
[10] Zhou, Y., Zhou, B., Pache, L., et al. (2019) Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets. Nature Communications, 10, Article No. 1523. [Google Scholar] [CrossRef] [PubMed]
[11] Bader, G.D. and Hogue, C.W. (2003) An Automated Method for Finding Molecular Complexes in Large Protein Interaction Networks. BMC Bioinformatics, 4, Article No. 2. [Google Scholar] [CrossRef] [PubMed]
[12] 华雯, 黄华琼, 沈华浩. 《支气管哮喘防治指南(2016年版)》解读[J]. 浙江大学学报: 医学版, 2016, 45(5): 447-452.
[13] 孔亚丽, 江玉平, 安妮. 糖皮质激素与β2受体激动剂吸入治疗对小儿哮喘患儿的肺功能改善研究[J]. 世界复合医学, 2020, 6(6): 196-198.
[14] 李阳杰, 姜亚玲, 刘秋伟, 翟广玉. 槲皮素衍生物的生物活性研究进展[J]. 中国药学杂志, 2021, 56(3): 175-180.
[15] Mlcek, J., Jurikova, T., Skrovankova, S., et al. (2016) Quercetin and Its Anti-Allergic Immune Response. Molecules, 21, Article No. 623. [Google Scholar] [CrossRef] [PubMed]
[16] Niu, X., Zhang, H., Li, W., et al. (2015) Anti-Inflammatory Effects of Cavidine in Vitro and in Vivo, a Selective COX-2 Inhibitor in LPS-Induced Peritoneal Macrophages of Mouse. Inflammation, 38, 923-933. [Google Scholar] [CrossRef] [PubMed]
[17] Niu, X., Liu, F., Li, W., et al. (2017) Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in Vivo and in Vitro. Inflammation, 40, 1111-1122. [Google Scholar] [CrossRef] [PubMed]
[18] Mizuguchi, H., Nariai, Y., Kato, S., et al. (2015) Maackiain is a Novel Antiallergic Compound That Suppresses Transcriptional Upregulation of the Histamine H1 Receptor and Interleukin-4 Genes. Pharmacology Research & Perspectives, 3, Article ID: e00166. [Google Scholar] [CrossRef] [PubMed]
[19] Wu, C., Zhao, W., Zhang, X., et al. (2015) Neocryptotanshinone Inhibits Lipopolysaccharide-Induced Inflammation in RAW264.7 Macrophages by Suppression of NF-κB and iNOS Signaling Pathways. Acta Pharmaceutica Sinica B, 5, 323-329. [Google Scholar] [CrossRef] [PubMed]
[20] 刘艳明, 农光民, 李树全. 哮喘小鼠气道IL-6、信号转导和转录激活因子3的表达与活化及其与气道炎症的关系[J]. 临床儿科杂志, 2011, 29(2): 165-169.
[21] Gosens, R., Zaagsma, J., Meurs, H., et al. (2006) Muscarinic Receptor Signaling in the Pathophysiology of Asthma and COPD. Respiratory Research, 7, Article No. 73. [Google Scholar] [CrossRef] [PubMed]
[22] Folino, A., Carriero, V., Bullone, M., et al. (2020) Muscarinic Receptor M3 Contributes to Vascular and Neural Growth Factor Up-Regulation in Severe Asthma. Allergy, 75, 717-720. [Google Scholar] [CrossRef] [PubMed]
[23] 林星, 李俊峰, 车楠, 李良昌, 李莉. 连翘酯苷A通过p38 MAPK/NF-κB信号抑制哮喘气道炎症[J]. 中国免疫学杂志, 2019, 35(24): 2971-2974+2979.
[24] Lai, J.L., Liu, Y.H., Liu, C., et al. (2017) Indirubin Inhibits LPS-Induced Inflammation via TLR4 Abrogation Mediated by the NF-kB and MAPK Signaling Pathways. Inflammation, 40, 1-12. [Google Scholar] [CrossRef] [PubMed]
[25] Zhang, Y., Cardell, L.O., Edvinsson, L., et al. (2013) MAPK/NF-κB-Dependent Upregulation of Kinin Receptors Mediates Airway Hyperreactivity: A New Perspective for the Treatment. Pharmacological Research, 71, 9-18. [Google Scholar] [CrossRef] [PubMed]
[26] Thomas, P.S. (2001) Tumour Necrosis Factor-Alpha: The Role of This Multifunctional Cytokine in Asthma. Immunology and Cell Biology, 79, 132-140. [Google Scholar] [CrossRef] [PubMed]
[27] 丘创华, 侯敢, 黄迪南. TNF-α信号传导通路的分子机理[J]. 中国生物化学与分子生物学报, 2007, 23(6): 430-435.